Japanese pharmaceutical company Shionogi has lifted its full-year profit guidance as expected royalties from its HIV treatment surpass prior expectations. https://www.japantimes.co.jp/business/2025/10/28/shionogi-raises-profit-outlook/?utm_medium=Social&utm_source=mastodon #business #shionogi #hiv #pharmaceutical
Update. "US conference boycott urged after French scientist deported"
https://archive.is/Wxwdg
"Academics say they are increasingly wary of travelling to conferences in the US after a French scientist was deported over text messages critical of Donald #Trump’s cuts to research funding … Space scientist Mark Wieczorek [@mrak], director of research at the Institut de Physique du Globe de Paris, part of CNRS, said the situation was “very troubling” and, despite being a dual US-French citizen, he now would “only go to the US for the case of a family emergency”…Given the French scientist in question is a “permanent researcher employed by CNRS”, it is “unlikely that this person is a radicalised terrorist and it is unlikely that their hatred of Trump is greater than mine as a US citizen,” continued Wieczorek."
Update. New study: "#NIH investment in drugs approved from 2010 to 2019 was not less than investment by the #pharmaceutical industry, with comparable accounting for basic and applied research, failed clinical trials, and cost of capital or discount rates."
https://jamanetwork.com/journals/jama-health-forum/fullarticle/2804378
PS: Relevant to (1) #Trump admin cutbacks to NIH #funding and (2) industry #patents and licensing terms on approved drugs.